SNOA News and Press, Sonoma Pharmaceuticals Inc. From 04/05/20

Following up on its initial announcements in January and February , Incyte (NASDAQ: INCY ) reports detailed results from two successful Phase 3 clinical trials, TRuE-AD1 and TRuE-AD2 , evaluating a topical cream formulation of kinase inhibitor ruxolitinib in adolescents and adults wi...

PETALUMA, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a specialty pharmaceutical company dedicated to identifying, developing and commercializing unique, differentiated therapies to millions of patients living with chronic skin and wound conditions...

Sonoma Pharmaceuticals (NASDAQ: SNOA ): Q3 GAAP EPS of -$0.72. More news on: Sonoma Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

PETALUMA, Calif., Feb. 14, 2020 (GLOBE NEWSWIRE) -- Quarterly Net Loss Reduced by 53% Compared to Prior Year YTD Net Loss Reduced by 82% Compared to Prior Year Total YTD Revenues of $14.4 Million Lower by 2% Compared to Prior Year Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), ...

PETALUMA, Calif., Jan. 23, 2020 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a specialty pharmaceutical company dedicated to identifying, developing and commercializing unique, differentiated therapies to millions of patients living with chronic skin conditions, today an...

PETALUMA, Calif., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) today announced the pricing of its previously announced “best efforts” public offering of shares of its common stock at a public offering price of $3.50 per share, with anticipated ...

Movado Group (NYSE: MOV )  -20%  on Q3 earnings . More news on: Movado Group, Inc., ASLAN Pharmaceuticals Limited, Sonoma Pharmaceuticals, Inc., Stocks on the move, Read more ...

Sonoma Pharmaceuticals (NASDAQ: SNOA ) launches a public offering of common shares. Price, volume and terms have yet to be announced. More news on: Sonoma Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...

PETALUMA, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) today announced the launch of a “best efforts” public offering of shares of its common stock. Dawson James Securities, Inc. is acting as the lead placement agent and sole book ru...

Sonoma Pharmaceuticals (NASDAQ: SNOA ): Q2 net loss of $1.2M Revenue of $4.96M (+0.4% Y/Y) beats by $0.26M . Press Release More news on: Sonoma Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,